Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, May 7, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
People on the Move
Parabilis Medicines Names Fawzi Benzaghou, M.D., as Chief Medical Officer
Life Sciences Times
-
September 3, 2025
0
People on the Move
Pretzel Therapeutics Appoints Ashish Dugar, Ph.D., MBA as Chief Development Officer
Life Sciences Times
-
September 3, 2025
0
Pharma
Treeline Biosciences Launches First Clinical Trials and Expands Funding to $1.1 Billion
Life Sciences Times
-
September 3, 2025
0
People on the Move
Element Care PACE Names Anthony Zizza, M.D. as Chief Medical Officer
Life Sciences Times
-
September 3, 2025
0
Technology
IMVARIA Secures NIH SBIR Grant to Advance AI-Powered Oncology Diagnostics
Life Sciences Times
-
September 3, 2025
0
People on the Move
DSG Global Appoints Bryan Christianson as Managing Director of Healthcare Practice
Life Sciences Times
-
September 2, 2025
0
People on the Move
Neurotech Appoints Peter J. McDonnell, M.D., to Board of Directors
Life Sciences Times
-
September 2, 2025
0
Medtech
Kerecis Showcases Fish-Skin Graft Technology at SAWC Fall 2025 in Las Vegas
Life Sciences Times
-
September 2, 2025
0
Healthcare
Corsera Health Launches to Extend Healthspan by Predicting and Preventing Cardiovascular Disease
Life Sciences Times
-
September 2, 2025
0
People on the Move
Aera Therapeutics Appoints Bill Querbes, Ph.D., as Chief Scientific Officer
Life Sciences Times
-
September 2, 2025
0
1
...
121
122
123
...
835
Page 122 of 835
Most Popular
Museum of Science Raises Record $1.8 Million at Stars of STEM Gala
May 7, 2026
enGene Reports Updated Interim Results From Bladder Cancer Trial
May 7, 2026
Elucid’s Plaque-IQ Wins MedTech Breakthrough Cardiology Technology Award
May 7, 2026
Scholar Rock Reports First-Quarter Results as FDA Review of Apitegromab Advances
May 7, 2026
Load more
Recent Comments
Recent Comments